CeriBell Inc. Common Stock (CBLL)

FairStock Score: 35/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I am looking for businesses that earn durable profits and sell at a sensible price. CeriBell has a promising niche: a point-of-care EEG platform with disposable headbands and AI seizure detection, aimed at acute care. The top line is moving. In fiscal 2025, the year ended 2025-12-31, revenue was $89.1 million, up from $65.4 million in fiscal 2024. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $28.1 million. But the bottom line is worsening. That same quarter produced a net loss of $19.3 million, and fiscal 2025 net loss was $53.4 million versus $40.5 million in fiscal 2024. Trailing free cash flow was negative $54.7 million, a FairStock calculation, for a negative 5.5% FCF yield. The company has modest debt, with D/E of 0.17, and a FairStock Altman Z-Score of 14.43, so near-term solvency does not look like the main issue. The issue is economics. ROE is -43.93%, ROCE is -23.38%, and the Piotroski F-Score is 3/9. At the 2026-10-13 close of $26.14, the FairStock P/B is 7.78 and P/E is -14.85. FairStock score is 35/100, and its Lynch rules assign no category because the company lost money in each of the last three years. Growth is real, but there is no demonstrated moat or margin of safety yet. I would need evidence of falling cash burn and a credible path to profits before calling this a value investment.

In plain English: CeriBell makes a bedside brain-wave monitoring system and disposable headbands and software used in hospitals. Revenue is growing, but the company is still losing money and using cash, so the business looks financially weak today. At $26.14, the shares look expensive compared with its current sales, accounting value and losses, even though investors may be paying for future growth.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer